Annual Short Term Debt
$2.65 M
+$279.00 K+11.78%
December 31, 2023
Summary
- As of February 26, 2025, BCRX annual short term debt is $2.65 million, with the most recent change of +$279.00 thousand (+11.78%) on December 31, 2023.
- During the last 3 years, BCRX annual short term debt has fallen by -$28.53 million (-91.51%).
- BCRX annual short term debt is now -93.37% below its all-time high of $39.96 million, reached on December 31, 2019.
Performance
BCRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$2.89 M
+$181.00 K+6.69%
September 30, 2024
Summary
- As of February 26, 2025, BCRX quarterly short term debt is $2.89 million, with the most recent change of +$181.00 thousand (+6.69%) on September 30, 2024.
- Over the past year, BCRX quarterly short term debt has increased by +$240.00 thousand (+9.06%).
- BCRX quarterly short term debt is now -94.22% below its all-time high of $49.96 million, reached on September 30, 2020.
Performance
BCRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BCRX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.8% | +9.1% |
3 y3 years | -91.5% | -90.8% |
5 y5 years | -92.2% | -91.7% |
BCRX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +45.6% | at high | +58.8% |
5 y | 5-year | -93.4% | +45.6% | -94.2% | +58.8% |
alltime | all time | -93.4% | -100.0% | -94.2% | -100.0% |
BioCryst Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.89 M(+6.7%) |
Jun 2024 | - | $2.71 M(-1.2%) |
Mar 2024 | - | $2.74 M(+3.5%) |
Dec 2023 | $2.65 M(+11.8%) | $2.65 M(+16.0%) |
Sep 2023 | - | $2.28 M(-9.8%) |
Jun 2023 | - | $2.53 M(+1.6%) |
Mar 2023 | - | $2.49 M(+5.1%) |
Dec 2022 | $2.37 M(+30.2%) | $2.37 M(+7.9%) |
Sep 2022 | - | $2.20 M(+2.9%) |
Jun 2022 | - | $2.13 M(+2.5%) |
Mar 2022 | - | $2.08 M(+14.4%) |
Dec 2021 | $1.82 M(-94.2%) | $1.82 M(-94.2%) |
Sep 2021 | - | $31.45 M(+1.5%) |
Jun 2021 | - | $30.98 M(-0.1%) |
Mar 2021 | - | $31.00 M(-0.6%) |
Dec 2020 | $31.18 M(-22.0%) | $31.18 M(-37.6%) |
Sep 2020 | - | $49.96 M(+0.1%) |
Jun 2020 | - | $49.93 M(+11.0%) |
Mar 2020 | - | $45.00 M(+12.6%) |
Dec 2019 | $39.96 M(+18.4%) | $39.96 M(+14.4%) |
Sep 2019 | - | $34.94 M(+19.1%) |
Jun 2019 | - | $29.34 M(+0.4%) |
Mar 2019 | - | $29.23 M(-13.4%) |
Dec 2018 | $33.75 M(-4.2%) | $33.75 M(+9.9%) |
Sep 2018 | - | $30.70 M(-13.5%) |
Jun 2018 | - | $35.51 M(+0.4%) |
Mar 2018 | - | $35.37 M(+0.4%) |
Dec 2017 | $35.22 M(+24.7%) | $35.22 M(+5.5%) |
Sep 2017 | - | $33.37 M(+6.1%) |
Jun 2017 | - | $31.46 M(+6.2%) |
Mar 2017 | - | $29.63 M(+4.9%) |
Dec 2016 | $28.24 M | $28.24 M(+0.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | - | $28.13 M(+0.4%) |
Jun 2016 | - | $28.02 M(+0.4%) |
Mar 2016 | - | $27.91 M(+0.4%) |
Dec 2015 | $27.80 M(-7.3%) | $27.80 M(-7.3%) |
Sep 2015 | - | $30.00 M(0.0%) |
Jun 2015 | - | $30.00 M(0.0%) |
Mar 2015 | - | $30.00 M(0.0%) |
Dec 2014 | $30.00 M(>+9900.0%) | $30.00 M(0.0%) |
Sep 2014 | - | $30.00 M(0.0%) |
Jun 2014 | - | $30.00 M(>+9900.0%) |
Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
Mar 2001 | - | $3000.00(-69.4%) |
Dec 2000 | $9800.00(-90.2%) | $9800.00(-42.4%) |
Sep 2000 | - | $17.00 K(-26.1%) |
Jun 2000 | - | $23.00 K(-12.5%) |
Mar 2000 | - | $26.30 K(-73.7%) |
Dec 1997 | $100.00 K(-50.0%) | $100.00 K(0.0%) |
Sep 1997 | - | $100.00 K(0.0%) |
Jun 1997 | - | $100.00 K(-50.0%) |
Mar 1997 | - | $200.00 K(0.0%) |
Dec 1996 | $200.00 K(-33.3%) | $200.00 K(-33.3%) |
Sep 1996 | - | $300.00 K(0.0%) |
Jun 1996 | - | $300.00 K(0.0%) |
Mar 1996 | - | $300.00 K(0.0%) |
Dec 1995 | $300.00 K(0.0%) | $300.00 K(0.0%) |
Sep 1995 | - | $300.00 K(+50.0%) |
Jun 1995 | - | $200.00 K(0.0%) |
Mar 1995 | - | $200.00 K(-33.3%) |
Dec 1994 | $300.00 K | $300.00 K(0.0%) |
Sep 1994 | - | $300.00 K(-25.0%) |
Jun 1994 | - | $400.00 K(0.0%) |
Mar 1994 | - | $400.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual short term debt year-on-year change?
- What is BioCryst Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?
What is BioCryst Pharmaceuticals annual short term debt?
The current annual short term debt of BCRX is $2.65 M
What is the all time high annual short term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual short term debt is $39.96 M
What is BioCryst Pharmaceuticals annual short term debt year-on-year change?
Over the past year, BCRX annual short term debt has changed by +$279.00 K (+11.78%)
What is BioCryst Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of BCRX is $2.89 M
What is the all time high quarterly short term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly short term debt is $49.96 M
What is BioCryst Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, BCRX quarterly short term debt has changed by +$240.00 K (+9.06%)